Medtronic (MDT) announced the appointment of Chad Spooner as chief financial officer, CFO, of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to become fully independent. Most recently, Spooner served as CFO at BIC
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT:
- KKR, Medtronic, Disney, Circle, Barrick: Trending by Analysts
- Medtronic’s Loop Recorder Study: A Potential Game-Changer in Cardiac Diagnostics
- Medtronic’s Care-HF Study: A Milestone in Cardiac Resynchronization Therapy
- Medtronic’s CORE Study Update: Evaluating the Conducted AF-Response Algorithm
- Medtronic’s ICD Study: A Step Forward in Cardiac Care